Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older.
Clinical trial NCT01855945 · COMPLETED
Trial details
- NCT number
- NCT01855945
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2014-09-01
- Enrollment
- 627
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.